Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rocket Pharmaceuticals (RCKT) Revenue (2016)

Rocket Pharmaceuticals (RCKT) has disclosed Revenue for 1 consecutive years, with $525000.0 as the latest value for Q4 2016.

  • Quarterly Revenue changed N/A to $525000.0 in Q4 2016 from the year-ago period, while the trailing twelve-month figure was $525000.0 through Sep 2017, changed N/A year-over-year, with the annual reading at -$1.2 million for FY2015, 25.51% down from the prior year.
  • Revenue hit $525000.0 in Q4 2016 for Rocket Pharmaceuticals, up from -$525000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $525000.0 in Q4 2016 to a low of -$525000.0 in Q3 2016.